Renata Cifkova
First Faculty of Medicine, Charles University in Prague
327 Papers
2.3K Citations
Renata Cifkova is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 68, co-authored 305 publications. Previous affiliations of Renata Cifkova include Masaryk University & Czechoslovak Academy of Sciences.
Chat about Author
Papers
Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study.
Renata Cifkova,Zdenka Škodová,Lánská,Adámková,E. Novozámská,M. Jozifova,M. Plaskova,Z. Hejl,Petrzílková Z,M. Galovcova,D. Palous +10 more
TL;DR: A high prevalence of hypertension is confirmed in the Czech population, detecting an increase in prevalence for the male population over a period of 3 years, and there is also a significant increase in the awareness of hypertension in males.
Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach
TL;DR: Gender-specific aspects of major conventional cardiovascular risk factors, including smoking, diabetes and hypertension, seem to be more harmful in women, and the question is whether there should not be lower thresholds for initiating drug treatment in women with Diabetes and hypertension.
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular. Versión corregida 22/07/2009
Ian D. Graham,Dan Atar,Knut Borch-Johnsen,Gudrun Boysen,Gunilla Burell,Renata Cifkova,Jean Dallongeville,Guy De Backer,Shah Ebrahim,Bjørn Gjelsvik,Christoph Herrmann-Lingen,Arno W. Hoes,Steve E. Humphries,Mike Knapton,Joep Perk,Silvia G. Priori,Kalevi Pyörälä,Željko Reiner,Luis M. Ruilope,Susana Sans-Menendez,Wilma J.M. Scholte op Reimer,Peter L. Weissberg,David A. Wood,John Yarnell,José Luis Zamorano +24 more
TL;DR: Cuarto Grupo de Trabajo Conjunto de la Sociedad Europea de Cardiología y otras Sociedades sobre Prevención de the Enfermedad Cardiovascular en the Práctica Clínica (constituido por representantes de nueve sociedades y expertos invitados)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence
Alberto Zanchetti,Lisheng Liu,Giuseppe Mancia,Gianfranco Parati,Guido Grassi,Marco Stramba-Badiale,Vincenzo Silani,Grzegorz Bilo,Giovanni Corrao,Antonella Zambon,Lorenza Scotti,Xin-Hua Zhang,Hayyan Wang,Yuqing Zhang,Xuezhong Zhang,Ting Rui Guan,Eivind Berge,Josep Redon,Krzysztof Narkiewicz,Anna F. Dominiczak,Peter M. Nilsson,Margus Viigimaa,Stéphane Laurent,Enrico Agabiti-Rosei,Zhaosu Wu,Dingliang Zhu,Jose L. Rodicio,Luis M. Ruilope,Nieves Martell-Claros,Fernando Pinto,Roland E. Schmieder,Michel Burnier,Maciej Banach,Renata Cifkova,Csaba Farsang,Alexandra Konradi,Irina Lazareva,Yuriy Sirenko,Maria Dorobantu,Arman Postadzhiyan,Rok Accetto,Bojan Jelaković,Dragan Lovic,Athanasios J. Manolis,Philippos Stylianou,Serap Erdine,Dror Dicker,Gangzhi Wei,Chengbin Xu,Hengge Xie,Antonio Coca,John T. O'Brien,Gary A. Ford +52 more
TL;DR: A new, large randomized controlled trial is needed to determine the optimal level of BP and LDL-C for the prevention of recurrent stroke and cognitive decline.
Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage
Renata Cifkova
- 01 Jan 2012
TL;DR: The estimation of total cardiovascular risk is essential for guiding the management of hypertension and subclinical organ damage should be also measured during treatment because there is evidence that regression of left ventricular hypertrophy and reduction of proteinuria are associated with improved prognosis.